Product image of Lactulosa Biomedica (Lactulose) supplied by GNH India

Lactulosa Biomedica

Active Ingredient:
Lactulose
Origin:
EU

Lactulosa Biomedica (Lactulose)

Lactulose, the active ingredient in Lactulosa Biomedica, is an osmotic laxative presented as an oral solution for oral use. It is employed to relieve constipation and to manage hepatic encephalopathy in patients with liver disease, helping to reduce blood ammonia levels.

GNH India supplies Lactulosa Biomedica as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across global markets. The company maintains rigorous quality control and provides reliable logistics for timely delivery.

Manufacturer / TM Owner

Biomedica, Spol. S R.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lactulose is an osmotic laxative used to treat conditions related to bowel motility and ammonia accumulation.

  • Constipation: softens stool and promotes regular bowel movements.
  • Hepatic encephalopathy: lowers colonic ammonia absorption, improving mental status in liver disease patients.
  • Hyperammonemia: reduces elevated blood ammonia levels, supporting metabolic balance.

How It Works

  • Lactulose remains largely unabsorbed in the small intestine, creating an osmotic gradient that retains water in the intestinal lumen, softening stool and stimulating peristalsis. In the colon, bacterial enzymes metabolize lactulose to short‑chain fatty acids, lowering colonic pH and converting ammonia to non‑absorbable ammonium, thereby decreasing systemic ammonia levels.

Side Effects

Lactulose may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

  • Abdominal bloating: feeling of fullness or swelling in the abdomen.
  • Flatulence: increased intestinal gas production.
  • Diarrhea: loose, watery stools.
  • Stomach cramps: intermittent abdominal pain.
  • Nausea: sensation of unease and urge to vomit.
  • Thirst: increased desire for fluids.

Serious or Rare Side Effects

  • Severe electrolyte imbalance: abnormal levels of sodium, potassium, or magnesium.
  • Dehydration: excessive loss of body water.
  • Allergic reaction: rash, itching, swelling, or difficulty breathing.
  • Severe abdominal pain: persistent, intense pain requiring medical attention.

Precautions & Warnings

Before initiating lactulose therapy, consider the following safety measures.

  • Renal function assessment: evaluate kidney health to avoid accumulation of metabolites.
  • Electrolyte monitoring: check sodium, potassium, and magnesium levels during treatment.
  • Diabetes caution: monitor blood glucose as lactulose contains fermentable sugars.
  • Intestinal obstruction avoidance: do not use in patients with known bowel blockage.
  • Discontinuation guidance: taper gradually under medical supervision to prevent rebound constipation.
  • Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Lactulose can interact with other medications, altering its efficacy or safety.

Major Interactions (Avoid)

  • Antidiarrheal agents (e.g., loperamide): may reduce lactulose's laxative effect.
  • Insulin or oral hypoglycemics: carbohydrate content can potentiate hypoglycemia.

Moderate Interactions (Monitor Closely)

  • Magnesium‑containing supplements: may enhance osmotic activity and cause diarrhea.
  • Broad‑spectrum antibiotics: can alter colonic flora, affecting lactulose metabolism.
  • Probiotic preparations: may modify bacterial conversion of lactulose, influencing efficacy.

Frequently Asked Questions

Lactulosa Biomedica contains lactulose, an osmotic laxative indicated for the relief of constipation and for the management of hepatic encephalopathy in patients with liver disease. It works by softening stools and reducing intestinal ammonia absorption.

Lactulose is poorly absorbed in the small intestine, creating an osmotic pull that retains water in the colon, softening stool and stimulating bowel movements. In the colon, bacteria ferment lactulose to short‑chain fatty acids, lowering pH and converting ammonia to non‑absorbable ammonium, thereby decreasing systemic ammonia levels.

The appropriate dose of Lactulosa Biomedica is determined by the prescribing healthcare professional based on the patient’s condition, severity, and response to therapy. Dosage may vary for constipation versus hepatic encephalopathy and should be individualized.

Safety data for lactulose in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lactulose is an osmotic laxative, differing from stimulant laxatives such as senna or bisacodyl. It not only softens stool but also lowers colonic ammonia, making it uniquely useful for hepatic encephalopathy, whereas stimulant agents primarily increase intestinal motility without affecting ammonia levels.

Lactulosa Biomedica should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, excessive heat and direct sunlight to maintain stability and potency.

The product is taken orally, usually as a liquid solution. It can be measured with a calibrated dosing device and swallowed directly or mixed with a small amount of water or juice, following the prescribing clinician’s instructions.

Serious risks, though uncommon, include severe electrolyte disturbances, dehydration, and allergic reactions such as rash or difficulty breathing. Patients should seek immediate medical attention if they experience these symptoms.

Lactulosa Biomedica is contraindicated in individuals with known intestinal obstruction, severe bowel perforation, or hypersensitivity to lactulose. Caution is also advised for patients with renal impairment or uncontrolled diabetes, and use should be guided by a healthcare professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Lactulose

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT